The Serum Institute of India (SII) said on Wednesday that the drugmaker will follow instructions from the central drug regulator on suspending the Oxford-AstraZeneca COVID-19 vaccine trial in India. The Controller General of Drugs of India (DCGI) issued a notice of demonstrative cause to the Serum Institute of India on …
Read More »
AstraZeneca Pausing Oxford Vaccine Clinical Trials (Representational) New Delhi: The central drug regulator has sent a notice to the Serum Institute of India (SII) for not informing it that the pharmaceutical giant AstraZeneca has paused clinical trials of the Oxford vaccine candidate for COVID-19 in other countries and also for …
Read More »
Even as AstraZeneca has paused the trials of its Covid-19 vaccine candidate after one of the participants in the UK developed an unexplained illness, more than 100 volunteers in India have completed the crucial week after receiving injections in the trials in phase two humans showing no adverse reaction. . …
Read More »
The Oxford company of an Indian-born professor announced Tuesday that its Indian partner, the Serum Institute of India (SIIPL), has started trials of a new virus-like particle (VLP) vaccine targeting Covid-19 that has the potential to offer a revolutionary new approach to combat the pandemic. Professor Sumi Biswas, CEO and …
Read More »
A new experimental Covid-19 vaccine from the University of Oxford has begun human trials in Australia in partnership with the Serum Institute of India, the world’s largest vaccine manufacturer. The shot was devised by SpyBiotech, a British company founded in Oxford in 2017 by researchers who worked alongside Adrian Hill …
Read More »
The whole world is waiting with great anticipation for a ‘safe and effective’ vaccine against the new coronavirus. Currently, three candidate vaccines are in different stages of testing in India. Two homegrown candidate vaccines, Covaxin from Bharat Biotech and ZyCoV-D from Zydus Cadila have already started the phase II clinical …
Read More »
A Bangladeshi pharmaceutical company has struck a deal with the Serum Institute of India (SII) to gain priority access to Covid-19 vaccines being developed by the world’s largest drug manufacturer. Pune-based Serum Institute, in partnership with AstraZeneca, the Gates Foundation, and the Gavi Vaccine Alliance, will produce 1 billion doses …
Read More »